SavedAdd your journal

Journals / Psikiyatride Güncel Yaklaşımlar / 2010 / Cilt: 2 - Sayı: 4

Malignant Catatonia

Malign Katatoni

Ayça ÖZKUL
Ali Akyol
Yusuf TAMAM
Pages
595–608
Publication Date
2010-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians should be aware of the fatal outcome of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Catatonia is a syndrome characterized by mutism, immobility, negativism, stereotypy, mannerisms, echophenomena, perseveration and passive obedience.
📊
Key Findings & Data:The underlying causes can be psychiatric or may be associated with general medical status or neurological diseases.
💡
Conclusion & Impact:Clinicians should be aware of the fatal outcome of the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Katatoni · Malign Katatoni · Nöroleptik Malign Sendrom

Abstract

Catatonia is a syndrome characterized by mutism, immobility, negativism, stereotypy, mannerisms, echophenomena, perseveration and passive obedience. The underlying causes can be psychiatric or may be associated with general medical status or neurological diseases. Additionally catatoni has two subtypes as malignant and nonmalignant catotonia. Main symptoms of malignant catatonia are hyperthermia and autonomic symptoms such as tachycardia, tachypnea and hyperhidrosis. It is important to make the diagnosis as early as possible for an appropriate medical treatment. Clinicians should be aware of the fatal outcome of the disease.

Özet

Katatoni mutizm, hareketsizlik, negativizm, stereotipi, mannerizm, ekofenomen, perseverasyon ve pasif itaat ile karakterize bir sendromdur. Altta yatan nedenler psikiyatrik olabildiği gibi nörolojik ve genel tıbbi durum ile ilişkili olabilir. Bunun yanı sıra katatoni malign ve malign olmayan olarak iki alt tipe ayrılır. Malign katatonide tabloya hipertermi, otonomik bulgular da eşlik eder. Otonomik bulgular arasında taşikardi, takipne, hiperhidrozis başta gelir. Hastalığın tanısının erken konması uygun tedavinin verilmesi açısından önemlidir. Klinisyenler bu hastalığın ölümcül seyredebileceğini bilmelidirler.

🔖

Cite This Article

ÖZKUL, A., Akyol, A., TAMAM, Y. (2010). Malignant Catatonia. Psikiyatride Güncel Yaklaşımlar, Cilt: 2 - Sayı: 4, 595–608. https://ajindex.com/articles/230200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kahlbaum KL. Catatonia. Baltimore, Johns Hopkins University Press, 1973.
  2. Fink M, Taylor MA. Catatonia: A Clinician’s Guide to Diagnosis and Treatment. Cambridge, UK, Cambridge University Press, 2003.
  3. Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1233-1241.
  4. Taylor M, Abrams R. Catatonia: prevalence and importance in the manic phase of manic depressive illness. Arch Gen Psychiatry 1977; 34:1223-1225.
  5. Hung Y, Huang T. Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 2006; 29:144-147.
  6. Ungvari GA, Rankin JF. Lorazepam monotherapy for catatonic stupor. J Clin Psychopharmacology 1989; 9:154. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137-143.
  7. Elia J, Dell M, Friedman D, Zimmerman R, Balamuth N, Ahmed A et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry 2005; 44:1145-1150.
  8. Fink M, Taylor MA. Catatonia: subtype or syndrome in DSM? Am J Psychiatry 2006; 163:1875-1876.
  9. Rosebush PI, Mazurek MF. A consideration of the mechanisms by which lorazepam might treat catatonia. J Clin Psychiatry 1991; 52:187-188.
  10. Salam SA, Pillai AK, Beresford TP. Lorazepam for psychogenic catatonia. Am J Psychiatry 1987; 144:1082-1083.
  11. Cook EH, Olson K, Pliskin N. Response of organic catatonia to risperidone. Arch Gen Psychiatry 1996; 53:82-83.
  12. Fricchione GL, Cassem NH, Hooberman D. Intravenous lorazepam in neuroleptic- induced catatonia J Clin Psychopharmacol 1983; 3:338-342.
  13. Abrams R, Taylor MA. Catatonia. A prospective clinical study. Arch Gen Psychiatry 1976; 33:579-581.
  14. Abrams R, Taylor MA, Storulow KAC. Catatonia and mania: Patterns of cerebral dysfunction. Biol Psychiatry 1979; 14:111-117.
  15. Detweiler MB, Mehra A, Rowell T, Kim KY, Bader G. Delirious mania and malignant catatonia: A report of 3 cases and review. Psychiatr Q 2009; 80:23-40. Morrison JR. Catatonia: Retarded and excited types. Arch Gen Psychiatry 1973; 28:39- 41. Morrison JR. Karl Kauhlbaum and catatonia. Compr Psychiatry 1974;15:315-316. Morrison JR. Catatonia: Diagnosis and treatment. Hosp Community Psychiatry 1975; 26:91-94. Gelenburg AJ. The catatonic syndrome. Lancet 1976;1 (7973): 339-341.
  16. Primavera A, Fonti A, Novello P, Roccatagliata G, Cocito L. Epileptic seizures in patients with acute catatonic syndrome. J Neurol Neurosu